Preferred Label : tafasitamab;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3330896/fr/minjuvi-tafasitamab-lymphome
2022
false
false
false
France
evaluation of the transparency committee
Lymphoma
lymphoma
tafasitamab
malignant lymphoma, nos
tafasitamab

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.